Nalbuphine Infusion Initiation Protocol
For adult postoperative patients, initiate nalbuphine with a loading dose of 0.1-0.2 mg/kg IV, followed by a continuous infusion of 80 mcg/kg/h (0.08 mg/kg/h), titrating based on pain response.
Loading Dose
Administer 0.1-0.2 mg/kg IV as a loading dose at the end of surgery or when initiating pain management 1. The FDA-approved dosing suggests 10 mg for a 70 kg individual (approximately 0.14 mg/kg), with a maximum single dose of 20 mg 2.
Sample Calculation for Loading Dose:
- 70 kg patient: 0.15 mg/kg × 70 kg = 10.5 mg IV bolus
- 80 kg patient: 0.15 mg/kg × 80 kg = 12 mg IV bolus
- 60 kg patient: 0.15 mg/kg × 60 kg = 9 mg IV bolus
Continuous Infusion Rate
Start continuous infusion at 80 mcg/kg/h (0.08 mg/kg/h) 3, 4. This translates to approximately 5 mg/h for a 70 kg patient.
Sample Calculation for Infusion:
For a 70 kg patient:
- 80 mcg/kg/h × 70 kg = 5,600 mcg/h = 5.6 mg/h
- If using nalbuphine 10 mg/mL concentration: 5.6 mg/h ÷ 10 mg/mL = 0.56 mL/h
For an 80 kg patient:
- 80 mcg/kg/h × 80 kg = 6,400 mcg/h = 6.4 mg/h
- If using nalbuphine 10 mg/mL: 0.64 mL/h
For a 60 kg patient:
- 80 mcg/kg/h × 60 kg = 4,800 mcg/h = 4.8 mg/h
- If using nalbuphine 10 mg/mL: 0.48 mL/h
Preparation of Infusion
Standard concentration: Use nalbuphine 10 mg/mL (undiluted) or dilute to desired concentration for infusion pump compatibility.
Alternative preparation for PCA/continuous infusion: Mix 100 mg nalbuphine in 100 mL normal saline (1 mg/mL concentration) for easier titration 5, 6.
Breakthrough Dosing
Bolus dose: 0.1-0.2 mg/kg IV every 15 minutes as needed 1, 2. If the patient requires two bolus doses within one hour, double the infusion rate 2.
Sample Breakthrough Calculation:
- 70 kg patient: 0.15 mg/kg × 70 kg = 10.5 mg IV (can repeat every 15 minutes)
- If two doses needed in one hour: increase infusion from 5.6 mg/h to 11.2 mg/h
Titration Strategy
The evidence shows significant variability in optimal dosing. Research demonstrates effective analgesia with doses ranging from 0.05-0.2 mg/kg for boluses 6:
- Initial 4 hours postoperatively: Use higher range (0.1-0.2 mg/kg boluses, 80 mcg/kg/h infusion)
- After 4 hours: May reduce to 0.05 mg/kg boluses if pain controlled 6
- Maximum daily dose: 160 mg per FDA guidelines 2
Age-Specific Considerations
For pediatric patients (>3 months): 0.1-0.2 mg/kg IV every 3-4 hours 1
For infants <3 months: Reduce to 0.05 mg/kg IV 1
Monitoring Requirements
- Respiratory rate and oxygen saturation: Nalbuphine causes less respiratory depression than pure mu-agonists but monitoring remains essential 2
- Pain scores: Target VAS ≤3 5
- Sedation level: Monitor Ramsay sedation score 5
- Blood pressure and heart rate: Nalbuphine provides better hemodynamic stability than morphine 7
Common Pitfalls to Avoid
Underdosing: The pediatric guidelines show nalbuphine is often used at 0.1-0.2 mg/kg for breakthrough pain 1, yet many clinicians start too conservatively. Research confirms 0.1-0.2 mg/kg provides superior analgesia to 0.05 mg/kg in the immediate postoperative period 6.
Inadequate loading: Starting infusion without a loading dose results in delayed analgesia. The loading dose achieves therapeutic levels immediately 3, 4.
Fixed dosing: Weight-based dosing is critical—a 50 kg patient requires 4 mg/h while a 90 kg patient needs 7.2 mg/h at the same mg/kg/h rate.
Ceiling effect concerns: While nalbuphine has a ceiling effect for respiratory depression, analgesia continues to improve with doses up to 0.2 mg/kg 6, 7.
Advantages Over Alternative Opioids
Nalbuphine demonstrates comparable analgesic efficacy to sufentanil in PCIA with fewer demands for additional analgesia and higher sedation scores, suggesting better overall comfort 5. Compared to morphine, nalbuphine offers lower risk of respiratory depression, better hemodynamic stability, and reduced addiction potential 7. The incidence of PONV is significantly lower with nalbuphine compared to other opioids 8.